Class 1 Medical System Registration Permits Nutriband To Discover New Product Manufacturing Alternatives By way of Its Wholly Owned Subsidiary Energetic Intelligence LLC
ORLANDO, FL / ACCESSWIRE / Might 11, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical merchandise, at the moment introduced its Energetic Intelligence LLC subsidiary has registered as a Class I medical machine producer with the U.S. Meals and Drug Administration (FDA) to fabricate and distribute its proprietary AI Tape, to compete within the rising kinesiology tape market.
Sponsored content material:
“The FDA medical machine manufacturing registration for Energetic Intelligence represents a pivotal milestone that paves the way in which for industrial gross sales of our AI Tape product in america,” commented Gareth Sheridan, CEO of Nutriband. “The registration will allow Energetic Intelligence to fabricate AI Tape underneath its personal model or by white label agreements with gross sales and advertising and marketing companions in addition to discover new alternatives for contract manufacturing within the medical machine house. We look ahead to offering the market with updates on the progress within the coming months.”
AI Tape is a kinesiology tape that’s positioned on the pores and skin to assist for athletes recovering from sports activities accidents. Energetic Intelligence can be creating a line of medicated kinesiology tapes to help athletes within the restoration course of after bodily harm. The worldwide sports activities drugs market exceeded $5 billion in 2021 and is projected to develop at a 6.8% CAGR by 2028, reaching an estimated $8.9 billion, in accordance with information from Statista.
About Nutriband Inc.
We’re primarily engaged within the growth of a portfolio of transdermal pharmaceutical merchandise. Our lead product underneath growth is an abuse deterrent fentanyl patch incorporating our AVERSA™ abuse deterrence expertise. AVERSA™ expertise could be included into any transdermal patch to forestall the abuse, misuse, diversion, and unintended publicity of medication with abuse potential.
The Firm’s web site is www.nutriband.com. Any materials contained in or derived from the Firm’s web sites or another web site just isn’t a part of this press launch.
Ahead-Wanting Statements
Sure statements contained on this press launch, together with, with out limitation, statements containing the phrases ‘’believes,” “anticipates,” “expects” and phrases of comparable import, represent “forward-looking statements” throughout the that means of the Personal Securities Litigation Reform Act of 1995. Such forward-looking statements contain each identified and unknown dangers and uncertainties. The Firm’s precise outcomes could differ materially from these anticipated in its forward-looking statements because of various components, together with these together with the Firm’s capacity to develop its proposed abuse deterrent fentanyl transdermal system and different proposed merchandise, its capacity to acquire patent safety for its abuse expertise, its capacity to acquire the required financing to develop merchandise and conduct the required medical testing, its capacity to acquire Federal Meals and Drug Administration approval to market any product it might develop in america and to acquire another regulatory approval essential to market any product in different nations, together with nations in Europe, its capacity to market any product it might develop, its capacity to create, maintain, handle or forecast its development; its capacity to draw and retain key personnel; modifications within the Firm’s enterprise technique or growth plans; competitors; enterprise disruptions; opposed publicity and worldwide, nationwide and native common financial and market situations and dangers usually related to an undercapitalized creating firm, in addition to the dangers contained underneath “Danger Elements” and “Administration’s Dialogue and Evaluation of Monetary Situation and Outcomes of Operations” within the Firm’s Kind S-1, Kind 10-Okay for the yr ended January 31, 2020 and Kinds 10-Q, and the Firm’s different filings with the Securities and Change Fee. Besides as required by relevant legislation, we undertake no obligation to revise or replace any forward-looking statements to mirror any occasion or circumstance that will come up after the date hereof.
https://www.marketwatch.com/press-release/sports-medicine-market-analysis-trend-growth-opportunity-forecast-2028-2022-04-27.
For extra info, contact:
Investor Relations
RedChip Corporations
Dave Gentry
[email protected]
1-800-RED-CHIP (733-2447)
407-491-4498
SOURCE: Nutriband Inc.
View supply model on accesswire.com:
https://www.accesswire.com/700874/Nutriband-Subsidiary-Energetic-Intelligence-LLC-Registers-with-FDA-as-a-Medical-System-Producer-for-its-AI-Kinesiology-Tape-Product
